| scholarly article | Q13442814 |
| P2093 | author name string | Jun-Jun Li | |
| Jian-Ming Ouyang | |||
| Jun-Fa Xue | |||
| P2860 | cites work | Glycosaminoglycans content of stone matrix. | Q50909609 |
| Urinary glycosaminoglycans and glycoproteins in a calcium oxalate crystallization system. | Q54608856 | ||
| Effects of a urolith prevention diet on urine compositions of glycosaminoglycans, Tamm-Horsfall glycoprotein, and nephrocalcin in cats with calcium oxalate urolithiasis | Q60577475 | ||
| Stability studies of chondroitin sulfate | Q62097096 | ||
| Significance of glycosaminoglycans for the formation of calcium oxalate stones | Q70126493 | ||
| Inactivation of Antiadherence Effect of Bladder Surface Glycosaminoglycan by A Complete Urinary Carcinogen (n-methyl-n-nitrosourea) | Q70242444 | ||
| A methodology for the characterization of urinary glycosaminoglycans | Q70471878 | ||
| Advantage of zero-crossing-point first-derivative spectrophotometry for the quantification of calcium oxalate crystalline phases by infrared spectrophotometry | Q73943167 | ||
| Possible causes for the low prevalence of pediatric urolithiasis | Q77878940 | ||
| Models for protein binding to calcium oxalate surfaces | Q79988047 | ||
| Impact of various modifiers on calcium oxalate crystallization | Q80149508 | ||
| Kidney models of calcium oxalate stone formation | Q80895368 | ||
| Splenda® improves tolerance of oral potassium citrate supplementation for prevention of stone formation: results of a randomized double-blind trial | Q84680124 | ||
| Effect of urinary stone disease and extracorporeal shockwave lithotripsy on excretion of glycosaminoglycans | Q28377605 | ||
| Calcium-induced changes in chondroitin sulfate chains of urinary trypsin inhibitor | Q30646796 | ||
| Morphology, particle size distribution, aggregation, and crystal phase of nanocrystallites in the urine of healthy persons and lithogenic patients | Q33566515 | ||
| Large-scale identification of calcium oxalate monohydrate crystal-binding proteins on apical membrane of distal renal tubular epithelial cells | Q34000365 | ||
| Interaction between submicron COD crystals and renal epithelial cells | Q34413559 | ||
| Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein | Q35050995 | ||
| Corneal sulfated glycosaminoglycans and their effects on trigeminal nerve growth cone behavior in vitro: roles for ECM in cornea innervation | Q36467201 | ||
| Changes in urinary nanocrystallites in calcium oxalate stone formers before and after potassium citrate intake | Q36659120 | ||
| Urinary excretion of glycosaminoglycans in normal and stone forming subjects | Q41284144 | ||
| Aggregation and dispersion characteristics of calcium oxalate monohydrate: effect of urinary species | Q44264965 | ||
| A novel assay to evaluate promoting effects of proteins on calcium oxalate crystal invasion through extracellular matrix based on plasminogen/plasmin activity | Q44584910 | ||
| Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate | Q44619949 | ||
| Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers | Q45255603 | ||
| Atorvastatin inhibits renal crystal retention in a rat stone forming model | Q46356334 | ||
| Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals | Q46654056 | ||
| A nidus, crystalluria and aggregation: key ingredients for stone enlargement | Q46887950 | ||
| Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth | Q46911529 | ||
| Stabilization of calcium oxalate suspension by urinary macromolecules, probably an efficient protection from stone formation | Q46947561 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | calcium oxalate | Q412399 |
| P304 | page(s) | 360142 | |
| P577 | publication date | 2013-12-08 | |
| P1433 | published in | Bioinorganic Chemistry and Applications | Q15757987 |
| P1476 | title | Stabilization of submicron calcium oxalate suspension by chondroitin sulfate C may be an efficient protection from stone formation | |
| P478 | volume | 2013 |
| Q92494538 | In Vitro Studies Reveal Antiurolithic Effect of Antioxidant Sulfated Polysaccharides from the Green Seaweed Caulerpa cupressoides var flabellata | cites work | P2860 |
Search more.